ID: ALA4760291

Max Phase: Preclinical

Molecular Formula: C8H13NO2

Molecular Weight: 155.20

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)OC1C=CCN(C)C1

Standard InChI:  InChI=1S/C8H13NO2/c1-7(10)11-8-4-3-5-9(2)6-8/h3-4,8H,5-6H2,1-2H3

Standard InChI Key:  NUSANDVHPIYSBF-UHFFFAOYSA-N

Associated Targets(non-human)

Choline trimethylamine-lyase 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 155.20Molecular Weight (Monoisotopic): 155.0946AlogP: 0.42#Rotatable Bonds: 1
Polar Surface Area: 29.54Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.69CX LogP: 0.36CX LogD: -0.11
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.41Np Likeness Score: 1.59

References

1. Bollenbach M,Ortega M,Orman M,Drennan CL,Balskus EP.  (2020)  Discovery of a Cyclic Choline Analog That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria.,  11  (10): [PMID:33062182] [10.1021/acsmedchemlett.0c00005]

Source